Offer of the Department of Commercialization and Technology Transfer

OFFER

Offer of the Department of Commercialization and Technology Transfer

Chemical Technologies

→ Method of obtaining caprolactam from textile waste containing polyamide 6

→ Recovery of nickel and cadmium from black mass nickel-cadmium batteries

→ Method of recovering zinc and manganese from black mass zinc batteries

→ Method of processing waste Tetra Pak multilayer composites using a binary solvent system

→ Halogen-free polymer composition with limited flammability obtained on the basis of polypropylene

→ Method of disposing of wastewater from the process of manufacturing fatty acid methyl esters→

→ Modified unsaturated polyester resin

→ Method of obtaining modified phenol-formaldehyde resin and a composition that reduces the flammability of plastics

→ Catalytic conversion of biomethanol to biofuels

→ Method of purifying waste wood, especially railroad sleepers, by means of supercritical carbon dioxide extraction

→ Technology for the production of modified thermoplastic starch and biodegradable composites with its participation for the manufacture of disposable products, including films

→ Development of auxiliary raw materials for vinyl polymer processing

→ Method of electroplating copper cross-linked conductive carbon matrices

→ Method of introducing active mass into the current collector of lead-acid battery electrodes

→ Electrochemical way to measure carbon monoxide gas content in hydrogen gas

→ Electrochemical way to recover metals from silicon photovoltaic cells

→ Liquid composition forming an electromagnetic field shielding coating

→ Liquid coating composition designed especially for the manufacture of temporary temperature stabilizing coatings

→ New ammonium ionic liquids, the method of their preparation and their application

→ Halogen-free, self-extinguishing polyurethane-polyisocyanurate foam with improved performance properties and the method of obtaining it

→ Polyamide composites with hybrid silica filler modified with graphene oxide

→ Polyamide composites with aerogel hybrid filler

→ Method of catalytic hydrodechlorination of liquid hydrocarbons

→ Method of regenerating the solvent used in the extraction distillation of mixtures of C4 unsaturated hydrocarbons

Green technologies

→ Method of separating quercetin from onions by extraction

→ Keratin hydrolysate and insoluble keratin carrier structure

→ Biopreparation for plant care

→ Composition of biologically active ingredients of natural origin

→ Biocidal and compostable food packaging

→ Hybrid biocides designed to protect various types of materials exposed to microorganisms

→ Biodegradable composite based on foamed plant biomass possibly with hygienizing properties

→ Method of obtaining chitosan-based films with the addition of fruit peel extract and natural plasticizers

→ Modern biodegradable and/or compostable materials

→ Preparation of biodegradable biopolymer P3HB (BIOBAKCIR)

Pharmaceutical technologies

→ Manufacturing a dietary supplement containing modified-release caffeine

→ Manufacture of the active pharmaceutical ingredient Bimatoprost

→ Manufacture of active pharmaceutical substance Bosentan used in cardiovascular drugs and a medicinal product for the treatment of pulmonary hypertension

→ Manufacture of the active pharmaceutical substance Cilostazol for the treatment of atherosclerosis of inflamed arteries and the technology of the medicinal product

→ Development of a method to obtain derivatives of a cytostatic named MELFALAN

→ Manufacture of the active pharmaceutical substance Eplerenone

→ Manufacture of active pharmaceutical substance Exemestane for the treatment of advanced breast cancer and technology of the pharmaceutical form of the preparation -coated tablets à 25 mg.

→ Construction and expression of a selected recombinant human monoclonal antibody in Escherichia coli bacteria

→ Blocking ELISA for the detection of antibodies to hemagglutinin of influenza viruses serotype H5

→ Work on obtaining recombinant IBV Avian Infectious Bronchitis Virus antigens

→ Molecular basis of structure, physicochemical properties and pharmaceutical form of human insulin and SK3R biotechnology-modified insulin

→ Spectrometric analysis of INSCG(21A)RR insulin analogues at successive stages of production

→ Preparation of recombinant human insulin and its analogues in Escherichia coli IBA cells

→ Prototype vaccine against highly pathogenic H5N1 avian influenza viruses

→ Prokaryotic expression system for recombinant protein production based on Escherichia coli

→ Manufacture of active pharmaceutical ingredient Lapatinib for the treatment of metastatic breast cancer, non-small cell lung cancer, bladder cancer, head and neck cancer and cancers of the digestive system, as well as technology for the manufacture of pharmaceutical form – 250 mg film-coated tablets

→ Manufacture of pharmaceutical active ingredient Loteprednol Etabonate used in ophthalmic drugs and pharmaceutical form – eye suspension

→ Manufacture of active pharmaceutical ingredient Nepafenac for ophthalmic drugs and pharmaceutical form – eye suspension

→ Manufacture of the active pharmaceutical substance Olopatadine used in ophthalmic drugs and the pharmaceutical form of the preparation – eye drops

→ Manufacture of active pharmaceutical substance Pemetrexed and technology of pharmaceutical form – lyophilisate à 100 mg, 500 mg, for the first-line treatment of advanced pleural mesothelioma

→ Manufacture of active pharmaceutical substance Prasugrel for anticoagulant prophylaxis and drug product technology

→ Manufacture of active pharmaceutical substance Sunitinib (in the form of malate) for the treatment of imatinib-resistant gastrointestinal tumors and advanced renal cell carcinoma and technology of pharmaceutical formulation-capsule à 12.5 mg, 25 mg, 50 mg

→ Manufacture of active pharmaceutical substance Temozolomide for glioma chemotherapy and pharmaceutical form – DC capsules containing 5 mg, 20 mg, 100 mg and 250 mg of active substance

→ Manufacture of the active pharmaceutical ingredient Travoprost for use in ophthalmic drugs and the pharmaceutical form of the drug in the form of drops

→ Diosgenin derivatives, the method of obtaining them and pharmaceuticals containing them

Contact

Ewa Śmigiera, PhD. Sc. Eng.

phone +48 22 568 22 43, 22 633 97 98, +48 510 968 563

ewa.smigiera@ichp.lukasiewicz.gov.pl